Chain Pharmaceuticals is developing phytocannabinoid medicines to help healthcare professionals optimize patient treatments. We have been leveraging advancements in machine learning for cannabinoid drug development since 2021. Our mission is to deliver cost-effective, efficient, and sustainable cannabinoid-based pharmaceutical products within expedited timeframes.
